Zum Inhalt springen
Radio Logo

Let's Talk Micro

Luis Plaza
Neueste Episode

264 Episoden

  • Let's Talk Micro

    253: Beyond CRE: Why Carbapenemase Testing Matters

    20.11.2026 | 53 Min.
    Carbapenem-resistant Enterobacterales (CRE) are a significant concern in clinical microbiology, but does carbapenem resistance always mean an organism produces a carbapenemase? And why is identifying the specific resistance mechanism so important?
    In this episode of Let's Talk Micro, Dr. Hannah Creager and Dr. Erin McCreary return to discuss carbapenemase testing and its implications for laboratory workflows and patient care. They explore the different mechanisms that can lead to carbapenem resistance, the changing landscape of carbapenemases such as KPC and NDM, and the importance of identifying specific enzymes to help guide antimicrobial therapy.
    The conversation also covers phenotypic and genotypic testing methods, recommendations for carbapenemase testing, and practical considerations for implementing testing workflows. Drawing from their experience at UPMC, Hannah and Erin discuss how collaboration between clinical microbiology, antimicrobial stewardship, infectious diseases, and infection prevention can help translate laboratory results into actionable information for patient care.
    Guests:
    Hannah Creager, PhD — University of Pittsburgh Medical Center (UPMC)

    Erin McCreary, PharmD — University of Pittsburgh Medical Center (UPMC)

    Sponsorship and Disclosures
    This episode is sponsored by CorMedix Therapeutics.
    Disclosures: Erin McCreary has served as a consultant for CorMedix, Shionogi, bioMerieux, Meitheal, Wockhardt, Beckman Coulter, and GSK. Hannah Creager has nothing to disclose.
    The views and opinions expressed are those of the speakers and do not necessarily reflect the views of CorMedix.
     
    Stay connected with Let's Talk Micro:
    Website: letstalkmicro.com

    Questions or feedback? Email me at letstalkmicro@outlook.com

    Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

    Support the podcast:
    Venmo

    Buy me a Ko-fi
  • Let's Talk Micro

    What's Trending? A Syndromic Surveillance Update (November 1–14, 2026)

    19.11.2026 | 6 Min.
    What's trending in respiratory pathogens across the United States?
    In this first surveillance update of What's Trending? A Syndromic Surveillance Update, a special mini-series from Let's Talk Micro, we explore respiratory pathogen activity during the first two weeks of November 2026 using data from BIOFIRE® FIREWORKS™ Trends.
    Influenza A H1-2009 detections are increasing nationally, but human rhinovirus/enterovirus remains the most frequently detected respiratory target. We also look at regional differences, including elevated influenza activity in the West and increasing respiratory syncytial virus (RSV) detections in the South.
    What do these detection rates tell us, and why is it important to compare weekly findings with longer-term trends?
    Join us as we break down the numbers, explore what they mean, and highlight the value of pathogen surveillance in understanding respiratory virus activity.
    Sponsored by bioMérieux. Insights provided by BIOFIRE® FIREWORKS™ Trends, powered by syndromic testing.
    Disclaimer
    The information presented in this segment is intended for informational and educational purposes only. Data are derived from aggregated, de-identified results from participating healthcare institutions using BIOFIRE® Syndromic molecular panels and contributing to BIOFIRE® FIREWORKS™ Trends. These data are not representative of all healthcare settings, patient populations, geographic regions, or diagnostic testing platforms, and do not reflect all testing performed within a community. Trends discussed should be interpreted within the context of local epidemiology, clinical practice, and public health guidance.
    Resources
    BIOFIRE FIREWORKS Trends: https://bit.ly/fireworks-trends

    BIOFIRE FIREWORKS Trends Reports: https://www.biomerieux.com/us/en/education/resource-hub/trends-reports.html?utm_source=lets-talk-micro&utm_medium=episode-show-notes&utm_campaign=whats-trending

    Stay connected with Let's Talk Micro:
    Website: letstalkmicro.com

    Questions or feedback? Email me at letstalkmicro@outlook.com

    Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

    Support the podcast:
    Venmo

    Buy me a Ko-fi
  • Let's Talk Micro

    LTM updates: What's Trending? A Look at Pathogen Surveillance

    17.11.2026 | 4 Min.
    What's trending in the world of pathogens? In this introductory episode of our new mini-series, we explore how data from routine diagnostic testing can help us better understand pathogen activity.
    Learn how testing results from participating healthcare facilities can provide insights into which pathogens are being detected and how those patterns change over time.
    We'll also discuss what you can expect from this series, beginning with respiratory pathogens and later exploring gastrointestinal pathogens.
    Sponsored by bioMérieux. Insights provided by BIOFIRE® FIREWORKS™ Trends, powered by syndromic testing.
    Stay connected with Let's Talk Micro:
    Website: letstalkmicro.com

    Questions or feedback? Email me at letstalkmicro@outlook.com

    Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

    Support the podcast:
    Venmo

    Buy me a Ko-fi
  • Let's Talk Micro

    252: Acid-Fast Bacilli (AFB): An Introduction

    13.11.2026 | 36 Min.
    It's time to revisit acid-fast bacilli (AFB)!
    What is acid-fastness? What stains are used to detect AFB, and how are AFB cultures processed?
    In this episode of Let's Talk Micro, Luis revisits a conversation with Dr. Filipe Muniz (Cerqueira) about the fundamentals of AFB. They discuss acid-fast staining, specimen processing, culture media, and the Runyon groups. Dr. Muniz also discusses nontuberculous mycobacteria (NTM), including examples of clinically relevant organisms and their characteristics.
    Whether you're new to clinical microbiology or looking for a refresher, tune in to this episode from the archives!
    Note: This episode was originally released on January 30TH  2025. At the time of recording, Dr. Muniz was serving as a clinical microbiology laboratory director at the University of Alabama at Birmingham (UAB). He is no longer in that role and is currently a medical student at UAB.
     
    Stay connected with Let's Talk Micro:
    Website: letstalkmicro.com

    Questions or feedback? Email me at letstalkmicro@outlook.com

    Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

    Support the podcast:
    Venmo

    Buy me a Ko-fi
  • Let's Talk Micro

    251: Cyclospora Outbreak 2026: Behind the Laboratory Response

    06.11.2026 | 1 Std.
    In 2026, a multistate outbreak of cyclosporiasis led to a significant increase in testing across clinical and public health laboratories. How did laboratories recognize the increase in cases? What diagnostic approaches were used, and how did laboratory data contribute to the outbreak investigation?
    In this episode of Let's Talk Micro, Luis is joined by Dr. Anisha Misra from Cleveland Clinic, Dr. Marie-Claire Rowlinson from bioMérieux, and Dr. Duane Newton from the Michigan Department of Health and Human Services to discuss the laboratory response to the 2026 Cyclospora outbreak.
    The conversation explores diagnostic methods for Cyclospora cayetanensis, the challenges of managing increased testing volumes, and the use of diagnostic data to identify emerging trends. The guests also discuss the role of molecular testing and sequencing in public health investigations, the importance of collaboration between clinical laboratories, industry, and public health agencies, and lessons learned that may help laboratories prepare for future outbreaks.
    Join us for a discussion about the critical role of clinical microbiology laboratories in outbreak detection, investigation, and response.
    Guests
    Anisha Misra, PhD — Cleveland Clinic

    Marie-Claire Rowlinson, PhD — bioMérieux

    Duane Newton, PhD — Michigan Department of Health and Human Services

    Resources
    CDC – Cyclosporiasis: https://www.cdc.gov/cyclosporiasis/

    CDC DPDx – Cyclosporiasis: https://www.cdc.gov/dpdx/cyclosporiasis/

    FDA – Cyclospora: https://www.fda.gov/food/foodborne-pathogens/cyclospora

    Stay connected with Let's Talk Micro:
    Website: letstalkmicro.com

    Questions or feedback? Email me at letstalkmicro@outlook.com

    Interested in being a guest on Let's Talk Micro? Fill out the form here: https://forms.gle/V2fT3asjfyusmqyi8

    Support the podcast:
    Venmo

    Buy me a Ko-fi
Weitere Biowissenschaften Podcasts
Über Let's Talk Micro
Clinical microbiology explained in simple terms, suitable for students and microbiologists alike. We discuss organisms, reactions, infectious diseases, and more. Hosted by Luis Plaza, a Medical Laboratory Scientist and microbiologist, who also shares his experiences in the field.
Podcast-Website

Höre Let's Talk Micro, Luft nach oben - der Beatmungspodcast und viele andere Podcasts aus aller Welt mit der radio.at-App

Hol dir die kostenlose radio.at App

  • Sender und Podcasts favorisieren
  • Streamen via Wifi oder Bluetooth
  • Unterstützt Carplay & Android Auto
  • viele weitere App Funktionen
Rechtliches
Social
v8.27.0 | © 2007-2026 radio.de GmbH
Built: 11/16/2026 - 1:18:40 PM